REGULATION OF ADENYLATE CYCLASE UPON TRANSFORMATION

NIH RePORTER · NIH · R01 · $96,785 · view on reporter.nih.gov ↗

Abstract

The objective of the proposed research is to determine the extent to which modifications of the guanine nucleotide-binding proteins Gs and Gi participate in the regulation of adenylate cyclase coincident with malignant transformation. Transformation of various cells by Rous and Kirsten sarcoma viruses will be empoloyed as models for investigation. An initial aim of the proposed research is the analysis of Gs and Gi function in relation to transformation. The ability of Gs and Gi to mediate activation and inhibition of adenylate cyclase in native plasma membranes and in reconstituted systems will be investigated. A subsequent aim is the development of antibodies specific for subunits of Gs and Gi. Antibodies will be elicited by immunization with conjugated synthetic peptides that correspond to hydrophilic regions of these proteins. Serum titer and specificity will be monitored by solid-phase techniques and procedures of immunoprecipitation. The third aim is the assessment of regulatory events that may impinge upon Gs and Gi in relation to transformation. Events to be investigated include alterations in level of Gs and Gi, alterations in relative levels of isozymic forms of these proteins, post-translational modification, and physical interactions with other proteins. This aim will be achieved by employment of radiolabel and immunological procedures. Alterations in basal activities of adenylate cyclase, and in the responsiveness of this enzyme to extracellular agents, have been suggested as participating in transformation, metastasis, differentiation, and progression of the cell cycle. The ultimate objective of the proposed research is to contribute to the understanding of the relationship between these alterations and the general phenomenon of cell proliferation. (N)

Key facts

NIH application ID
3179068
Project number
5R01CA039712-03
Recipient
UNIVERSITY OF PENNSYLVANIA
SAM.gov UEI
GM1XX56LEP58
Principal Investigator
David Randell Manning
Activity code
R01
Funding institute
NIH
Fiscal year
1987
Award amount
$96,785
Award type
5
Project period
1985-04-01 → 1988-03-31